Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 0904-6805

11 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 0904-6805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (486bd7e7 86bb 44cb 98fc 33584ddcfe98 10)

Structural Formula (486bd7e7 86bb 44cb 98fc 33584ddcfe98 10)
Chemical structure diagram showing the molecular structure of quetiapine, the active ingredient. The image includes detailed representation of rings and bonds characteristic of the quetiapine molecule combined with a chemical group indicative of a salt or complex form.*
FDA Label Image

Figure 1 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 09)

Figure 1 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 09)
Kaplan-Meier curves showing the time to schizophrenic relapse over seven months comparing placebo (PLA) with Quetiapine extended-release (QTP XR). The y-axis represents the proportion of patients with relapse (%) and the x-axis represents time in months. The graph indicates lower relapse rates over time with Quetiapine XR versus placebo.*
FDA Label Image

Figure 2 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 08)

Figure 2 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 08)
A Kaplan-Meier survival curve graph showing the proportion of patients with relapse over time in weeks. The graph includes two curves comparing QTP + LIVAL treatment versus PLA + LIVAL treatment, indicating relapse proportions up to 100 weeks.*
FDA Label Image

Figure 3 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 07)

Figure 3 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 07)
Kaplan-Meier curves showing the proportion of patients with relapse of a mood event over time in weeks. Two curves represent groups labeled as QTP + LIVAL and PLA + LIVAL, comparing relapse rates over approximately 100 weeks.*
FDA Label Image

Logo (486bd7e7 86bb 44cb 98fc 33584ddcfe98 06)

Logo (486bd7e7 86bb 44cb 98fc 33584ddcfe98 06)
Quetiapine 300 mg extended-release film-coated tablets packaging by Major Pharmaceuticals. The image shows a blister pack with 10 round, white tablets arranged vertically in two rows. Each tablet is marked with '300' indicating the 300 mg strength.*
FDA Label Image

Logo 2 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 05)

Logo 2 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 05)
Quetiapine 150 mg extended-release film-coated tablets packaging by Major Pharmaceuticals. The box is predominantly white with blue accents and displays the strength (150 mg) clearly. The front label includes the product name Quetiapine and the labeler Major Pharmaceuticals. The package contains 1 tablet.*
FDA Label Image

50mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 04)

50mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 04)
Label for Quetiapine Extended-Release Tablets USP 50 mg by Major Pharmaceuticals. The label indicates a unit dose with 100 tablets (10 x 10), for oral use. It includes dosing instructions, storage conditions at 25°C, a warning on child safety, and distributor details in Indianapolis, IN, USA. The label also displays the NDC 0904-6801-61 and a barcode.*
FDA Label Image

150mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 03)

150mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 03)
Quetiapine Extended-Release 150 mg tablet label from Major Pharmaceuticals. This label states the dosage form as film-coated extended-release tablets, available in a 100-tablet unit dose package. It includes usage instructions, storage conditions, warning, and labeling details, with packaging and distribution by Major Pharmaceuticals, Indianapolis, IN, USA.*
FDA Label Image

200mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 02)

200mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 02)
Quetiapine Extended-Release 200 mg oral tablets by Major Pharmaceuticals. The label indicates 100 film-coated tablets in unit dose packaging, with instructions to swallow whole and a usual dosage of once daily. The product is prescription-only, with storage instructions and a warning to keep out of reach of children. Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN.*
FDA Label Image

300mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 01)

300mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 01)
Label for Quetiapine Extended-Release Tablets USP 300 mg by Major Pharmaceuticals. The label indicates unit dose packaging of 100 tablets (10 x 10), with instructions for once daily use and pharmacist dispensing with medication guide. It includes storage instructions, warnings, and packaging details, noting the product is from India and distributed by Major Pharmaceuticals, Indianapolis, IN.*
FDA Label Image

400mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 00)

400mg Carton Label (486bd7e7 86bb 44cb 98fc 33584ddcfe98 00)
Label for Quetiapine Extended-Release Tablets USP 400 mg by Major Pharmaceuticals. The unit dose package contains 100 film-coated tablets (10 x 10). The label includes dosage instructions, storage conditions, and a warning that the unit dose package is not child resistant and is for institutional use only. The label also lists packaging and distribution information from Major Pharmaceuticals, Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.